Avicanna is a Canadian biopharmaceutical company providing the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms including API, medical, pharmaceutical, and dermacosmetic. As a multinational organization with vertical integration , Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products through its internal research platforms and strategic collaborations with world-class research institutions.
Avicanna’s years of research and development was conducted at its Canadian headquarters within the Johnson & Johnson Innovation Centre (JLABS@Toronto) at MaRS, and through an exclusive research agreement at the Leslie Dan Faculty of Pharmacy at the University of Toronto.
March, 2024
Friday
August 26,2019
We have received your appointment and will send you a confirmation to your provided email upon approval.